Brief: Alligator Bioscience Gets Patent In United States
10/03/2026 12:37
March 10 (Reuters) - Alligator Bioscience AB ATORX.ST: UNITED STATES PATENT AND TRADEMARK OFFICE GRANTS PATENT COVERING ALLIGATOR BIOSCIENCE'S BISPECIFIC ANTIBODY FORMAT PATENT PROVIDES PROTECTION FOR TETRAVALENT BISPECIFIC ANTIBODIES WITH DUAL ANTIGEN BINDING Source text: ID:nMFN5KglHF Further company coverage: ATORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln